Damien Dessis is Chief Business Officer at Vitrivax. Damien is an experienced business development executive in the vaccine and biotech industry, with a strong track record across global markets. Over the course of his career, he has developed broad expertise in deal structuring, financial valuation, negotiation, and complex partnering transactions, helping organizations build value through strategic collaborations and portfolio growth. Damien has held senior business development roles at GSK Vaccines, Valneva, and various smaller organizations, where he helped advance innovative vaccines through strategic partnerships. His strategic vision and keen understanding of industry trends have allowed him to forge successful alliances and transactions, creating significant value and growth for organizations. With more than 20 years in the biotech and pharmaceutical industries, Damien has worked closely with both established companies and emerging start-ups, supporting them in areas such as business modeling and positioning, strategic planning, fundraising, and deal-making activities. Known for his pragmatic collaborative approach and analytical mindset, he combines scientific understanding with commercial acumen to deliver sustainable results. Damien holds a postgraduate diploma in international industrial project management from the University of Strasbourg, France; a Master’s Degree in innovation in biology from Polytech Angers, France; and has completed Executive Programs at Harvard Business School (Negotiation) and INSEAD (Finance).